Immediate Impact
4 from Science/Nature 59 standout
Citing Papers
Understanding and targeting resistance mechanisms in cancer
2023 Standout
WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective
2023 Standout
Works of Nicolás Schmidt being referenced
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Nicolás Schmidt | 37 | 2 | 63 | 92 | 89 | 19 | 495 | |
| M M Esiri | 69 | 97 | 45 | 16 | 434 | |||
| Tadeusz Foniok | 25 | 59 | 83 | 18 | 479 | |||
| Michelle Tran | 72 | 31 | 49 | 28 | 564 | |||
| Pernille Iversen | 142 | 83 | 95 | 24 | 553 | |||
| Sachiko Hara | 58 | 73 | 46 | 15 | 427 | |||
| Yikai Xu | 108 | 35 | 145 | 28 | 533 | |||
| Juanjuan Xie | 16 | 65 | 32 | 24 | 532 | |||
| Yuichi Komaba | 23 | 72 | 45 | 28 | 436 | |||
| Jung-Eun Choi | 13 | 69 | 82 | 26 | 486 | |||
| Toru Nanmoku | 1 | 97 | 29 | 74 | 36 | 567 |
All Works
Login with ORCID to disown or claim papers
Loading papers...